Acute Coronary Syndromes

  • Paul Ellis Marik


In the United States, more than a million people are hospitalized annually with unstable angina or myocardial infarction without ST segment elevation (NSTEMI), so-called acute coronary syndromes (ACS’s). For these patients, several treatments have proved to be effective in reducing the incidence of death, infarction or reinfarction, and recurrent ischemia. These treatments include intensive medical therapy and coronary angiography followed by revascularization, if indicated.


Unstable Angina Morphine Sulfate Intensive Medical Therapy Total Risk Score Serum Cardiac Marker 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Savonitto S, Ardissino D, Granger CB, et al. Prognostic value of the admission electrocardiogram in acute coronary syndromes. JAMA. 1999;281:707–713.PubMedCrossRefGoogle Scholar
  2. 2.
    Savonitto S, Cohen MG, Politi A, et al. Extent of ST-segment depression and cardiac events in non-ST-segment elevation acute coronary syndromes. Eur Heart J. 2005;26:2106–2113.PubMedCrossRefGoogle Scholar
  3. 3.
    Alpert JS, Thygesen K, Antman E, et al. Myocardial infarction redefined – a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol. 2000;36:959–969.PubMedCrossRefGoogle Scholar
  4. 4.
    Antman EM, Tanasijevic MJ, Thompson B, et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med. 1996;335:1342–1349.PubMedCrossRefGoogle Scholar
  5. 5.
    Antman EM, Cohen M, Bernink PJ, et al. The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA. 2000;284:835–842.PubMedCrossRefGoogle Scholar
  6. 6.
    Eagle KA, Lim MJ, Dabbous OH, et al. A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. JAMA. 2004;291:2727–2733.PubMedCrossRefGoogle Scholar
  7. 7.
    Hillis LD, Lange RA. Optimal management of acute coronary syndromes. N Engl J Med. 2009;360:2237–2240.PubMedCrossRefGoogle Scholar
  8. 8.
    Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines – Executive Summary. J Am Coll Cardiol. 2007;50:652–726.CrossRefGoogle Scholar
  9. 9.
    Meine TJ, Roe MT, Chen AY, et al. Association of intravenous morphine use and outcomes in acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative. Am Heart J. 2005;149:1043–1049.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Division of Pulmonary and Critical Care MedicineEastern Virginia Medical SchoolNorfolkUSA

Personalised recommendations